Jeffrey Del Carmen, Chief Commercial Officer of Catalyst Pharmaceuticals ( CPRX +0.06%), exercised and immediately sold ...
SOUTH SAN FRANCISCO, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO) (the “Company”) today announced that in connection with its previously announced public offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback